FuzeBio written research, as of 2026-09-17
Pfizer is a global biopharmaceutical company that develops and sells medicines and vaccines, with major focus areas including cancer, heart and metabolic disease, inflammation, and infectious disease; it makes money today from marketed products such as Eliquis, Prevnar, Vyndaqel, Ibrance, Comirnaty, and Paxlovid. (sec.gov) Its most important technology is the messenger-RNA platform used in Comirnaty, an approved and marketed COVID-19 vaccine rather than a development-stage product. (sec.gov) Pfizer’s next growth efforts are its late-stage cancer pipeline and obesity program, with several pivotal study readouts expected over the 12 months following the fiscal quarter ended June 28, 2026. (sec.gov)